Glac Biotech B.animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023

Glac Bifidobacterium animalis subsp. Lactis CP-9 as a patented probiotic can support weight management and regulate blood lipid and blood sugar levels. Especially, has clinically proven effects on body weight/fat loss and reduction on blood LDL-cholesterol and blood sugar levels. According to clincal study, administration for 8 weeks without changing the subject's lifestyle, the weight and BMI difference between placebo and probiotic group can be up to 4.7% and 2% respectively. That’s the reason why CP-9 can receive Australia TGA complementary medicine certificate in weight management category. How does Bifidobacterium animalis subsp. Lactis CP-9 provides unique nutritional solutions to this consumer need or problem：

No results found